Edwards Lifesciences officer has 923 shares withheld

A senior officer of Edwards Lifesciences had shares withheld on two September 2026 dates to satisfy tax obligations from vesting equity awards, not open-market sales.

Rhea-AI Filing Summary

Edwards Lifesciences Corp (EW) reported that officer Wayne Markowitz, CVP, JAPAC, had common shares withheld to cover tax obligations related to equity vesting. On September 11, 2026, 355 shares were withheld at $86.77 per share, and on September 14, 2026, 568 shares were withheld at $84.37 per share. A footnote states these shares were withheld by the company to satisfy tax withholding obligations incident to vesting under Rule 16b-3(e), rather than representing open-market sales.

Insider Trade Summary

Tax Withholding: 923 shares

Tax Withholding 2 txns

Insider Markowitz Wayne

Role CVP, JAPAC

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	568	$84.37	$48K
Tax Withholding	Common Stock F1	355	$86.77	$31K

Holdings After Transaction: Common Stock — 19,370.5581 shares (Direct)

Footnotes (1)

1. F1. Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).

Key Figures

Shares withheld for tax on September 11, 2026: 355 shares Per-share value on September 11, 2026: $86.77 per share Shares withheld for tax on September 14, 2026: 568 shares +2 more

5 metrics

Shares withheld for tax on September 11, 2026 355 shares Common stock withheld to satisfy tax withholding obligations

Per-share value on September 11, 2026 $86.77 per share Used for tax-withholding disposition of 355 shares

Shares withheld for tax on September 14, 2026 568 shares Common stock withheld to satisfy tax withholding obligations

Per-share value on September 14, 2026 $84.37 per share Used for tax-withholding disposition of 568 shares

Total shares for tax withholding 923 shares Aggregate of both Form 4 tax-withholding dispositions

Key Terms

Rule 16b-3(e), tax withholding obligations, beneficial ownership

3 terms

Rule 16b-3(e) regulatory

"incident to the vesting of securities in accordance with Rule 16b-3(e)"

tax withholding obligations financial

"shares withheld by the Issuer to satisfy tax withholding obligations incident"

beneficial ownership financial

"reflects changes in beneficial ownership only; it does not identify other securities"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did EW report for Wayne Markowitz on this Form 4?

The Form 4 reports that Wayne Markowitz had a total of 923 shares of Edwards Lifesciences common stock withheld in two transactions to satisfy tax withholding obligations related to vesting equity awards, not open-market purchases or sales.

On what dates did the EW tax-withholding share dispositions occur?

The dispositions occurred on September 11, 2026 and September 14, 2026. Both involved shares of Edwards Lifesciences common stock withheld by the issuer in connection with the vesting of equity awards and related tax obligations.

How many EW shares were withheld in each tax-withholding transaction?

On September 11, 2026, 355 shares of Edwards Lifesciences common stock were withheld. On September 14, 2026, an additional 568 shares were withheld. Both transactions are coded as tax-withholding dispositions rather than market trades.

What prices per share were used for the EW tax-withholding transactions?

The September 11, 2026 transaction used a price of $86.77 per share, and the September 14, 2026 transaction used a price of $84.37 per share. These prices are reported as the per-share values for the tax-withholding share dispositions.

Were the EW Form 4 transactions made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not affirmed, and the footnote describes the transactions as shares withheld by the issuer for tax withholding obligations on vesting under Rule 16b-3(e), not as trades under a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 06:04 PM Accepted by SEC EDGAR 09/14/2026 - 06:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Markowitz Wayne

(Last) (First) (Middle)

ONE EDWARDS WAY

(Street)

IRVINE CALIFORNIA 92614

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Edwards Lifesciences Corp [ EW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CVP, JAPAC

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2026		F(1)		355	D	$86.77	19,938.5581	D
Common Stock	09/14/2026		F(1)		568	D	$84.37	19,370.5581	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

	Linda J. Park, Attorney-in-Fact	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)